Printer Friendly

COMPANY INFORMATION
The Westaim Corporation 1010-144 4 Ave SW Calgary, AB T2P 3N4 Tel: (403) 237-7272 Fax: (403) 237-8181 Contact Name Philip R. Greer Industry Other Diversified Financial Services		Key Executives J. Cameron MacDonald, CEO Jeffrey A. Sarfin, CFO Holds 75% interest in NUCRYST Pharmaceuticals Corp., which formerly developed, manufactured and marketed medical products that fight infection and inflammation based on its nanocrystalline silver technology.
FP ADVISOR COVERAGE The Westaim Corporation • FP Corporate Analyzer • FP Directory of Directors • FP Corporate Surveys • FP Investor Reports • Ordering FP Products		TOP INDUSTRY PLAYERS Other Diversified Financial Services Company Name Revenue ($000s)  Central Fund of Canada Limited 859,091 Newport Partners Income Fund 669,730 Davis + Henderson Income Fund 367,231 Clarke Inc. 250,145 TerraVest Income Fund 241,711 (Links are to Snapshots.)
FINANCIAL RATIOS AS OF FEB 8/10 Listed Close 52-wk High 52-wk Low IAD Latest Dividend Yield 60-mo Beta TSX/WED $0.59 $0.65 $0.23 n.a. n.a. n.a. 0.73 Avg 20-day Volume P/E 12-mo EPS EPS Date 1-yr Return 3-yr Return 5-yr Return Market Cap. (000s) 541,562 n.a. $-0.05 Sept. 30/09 126.92% -25.03% -29.43% $55,590
ANNUAL FINANCIALS Periods ended: 12m Dec. 31/08 12m Dec. 31/07 12m Dec. 31/06 $000s $000s $000s Operating revenue 22,397 31,830 27,591 Net income (10,235) (58,033) (50,557) Total assets 77,277 83,387 148,339 $ $ $ Earnings per share* (0.11) (0.62) (0.54) % % % Return on equity (3.26) (3.34) (37.36)   * Common
TRAILING 12-MONTH VALUES Periods ended: Sept. 30/09 Sept. 30/08 $000s $000s Operating revenue 24,613 26,603 Net income (1,398) (38,673) $ $ Earnings per share (0.01) (0.42)

COMPANY NEWS

Results for 'The Westaim Corporation' from past 30 days: 1 hit. Kingsway to sell Jevco Insurance National Post - Tue Jan 26 2010 - 129 words (Links are to articles.)